 | • レポートコード：MRC2-11QY12168 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はC型肝炎ウイルス（HCV）抗ウイルス剤のグローバル市場について調査・分析したレポートです。種類別（HCV抗体、HCVウイルス量、HCVジェノタイピング）市場規模、用途別（診断センター、病院、家庭）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別C型肝炎ウイルス（HCV）抗ウイルス剤の競争状況、市場シェア ・世界のC型肝炎ウイルス（HCV）抗ウイルス剤市場：種類別市場規模 2015年-2020年（HCV抗体、HCVウイルス量、HCVジェノタイピング） ・世界のC型肝炎ウイルス（HCV）抗ウイルス剤市場：種類別市場規模予測 2021年-2026年（HCV抗体、HCVウイルス量、HCVジェノタイピング） ・世界のC型肝炎ウイルス（HCV）抗ウイルス剤市場：用途別市場規模 2015年-2020年（診断センター、病院、家庭） ・世界のC型肝炎ウイルス（HCV）抗ウイルス剤市場：用途別市場規模予測 2021年-2026年（診断センター、病院、家庭） ・北米のC型肝炎ウイルス（HCV）抗ウイルス剤市場分析：米国、カナダ ・ヨーロッパのC型肝炎ウイルス（HCV）抗ウイルス剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのC型肝炎ウイルス（HCV）抗ウイルス剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のC型肝炎ウイルス（HCV）抗ウイルス剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのC型肝炎ウイルス（HCV）抗ウイルス剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Diagnostics、Abbott、Siemens、Qiagen、bioMérieux、Bio-Rad Laboratories、Meridian Bioscience、Vista Diagnostics、Biogate Laboratories、J.Mitra & Co. Ltd、Siemens Medical、General Biologicals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.
Market Analysis and Insights: Global Hepatitis C Virus (HCV) Antiviral Market
The global Hepatitis C Virus (HCV) Antiviral market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hepatitis C Virus (HCV) Antiviral Scope and Market Size
Hepatitis C Virus (HCV) Antiviral market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis C Virus (HCV) Antiviral market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Diagnostics
Abbott
Siemens
Qiagen
bioMérieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
J.Mitra & Co. Ltd
Siemens Medical
General Biologicals
Market segment by Type, the product can be split into
HCV Antibody
HCV Viral Load
HCV Genotyping
Market segment by Application, split into
Diagnostic Centers
Hospitals
Home Use
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Antiviral Revenue
1.4 Market by Type
1.4.1 Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 HCV Antibody
1.4.3 HCV Viral Load
1.4.4 HCV Genotyping
1.5 Market by Application
1.5.1 Global Hepatitis C Virus (HCV) Antiviral Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Centers
1.5.3 Hospitals
1.5.4 Home Use
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis C Virus (HCV) Antiviral Market Perspective (2015-2026)
2.2 Global Hepatitis C Virus (HCV) Antiviral Growth Trends by Regions
2.2.1 Hepatitis C Virus (HCV) Antiviral Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hepatitis C Virus (HCV) Antiviral Historic Market Share by Regions (2015-2020)
2.2.3 Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hepatitis C Virus (HCV) Antiviral Market Growth Strategy
2.3.6 Primary Interviews with Key Hepatitis C Virus (HCV) Antiviral Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Market Size
3.1.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue (2015-2020)
3.1.2 Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Players (2015-2020)
3.1.3 Global Hepatitis C Virus (HCV) Antiviral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio
3.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Antiviral Revenue in 2019
3.3 Hepatitis C Virus (HCV) Antiviral Key Players Head office and Area Served
3.4 Key Players Hepatitis C Virus (HCV) Antiviral Product Solution and Service
3.5 Date of Enter into Hepatitis C Virus (HCV) Antiviral Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020)
5.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hepatitis C Virus (HCV) Antiviral Market Size (2015-2020)
6.2 Hepatitis C Virus (HCV) Antiviral Key Players in North America (2019-2020)
6.3 North America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020)
6.4 North America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hepatitis C Virus (HCV) Antiviral Market Size (2015-2020)
7.2 Hepatitis C Virus (HCV) Antiviral Key Players in Europe (2019-2020)
7.3 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020)
7.4 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020)
8 China
8.1 China Hepatitis C Virus (HCV) Antiviral Market Size (2015-2020)
8.2 Hepatitis C Virus (HCV) Antiviral Key Players in China (2019-2020)
8.3 China Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020)
8.4 China Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hepatitis C Virus (HCV) Antiviral Market Size (2015-2020)
9.2 Hepatitis C Virus (HCV) Antiviral Key Players in Japan (2019-2020)
9.3 Japan Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020)
9.4 Japan Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size (2015-2020)
10.2 Hepatitis C Virus (HCV) Antiviral Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020)
11 India
11.1 India Hepatitis C Virus (HCV) Antiviral Market Size (2015-2020)
11.2 Hepatitis C Virus (HCV) Antiviral Key Players in India (2019-2020)
11.3 India Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020)
11.4 India Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hepatitis C Virus (HCV) Antiviral Market Size (2015-2020)
12.2 Hepatitis C Virus (HCV) Antiviral Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction
13.1.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Introduction
13.2.4 Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Siemens
13.3.1 Siemens Company Details
13.3.2 Siemens Business Overview
13.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Introduction
13.3.4 Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.3.5 Siemens Recent Development
13.4 Qiagen
13.4.1 Qiagen Company Details
13.4.2 Qiagen Business Overview
13.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Introduction
13.4.4 Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.4.5 Qiagen Recent Development
13.5 bioMérieux
13.5.1 bioMérieux Company Details
13.5.2 bioMérieux Business Overview
13.5.3 bioMérieux Hepatitis C Virus (HCV) Antiviral Introduction
13.5.4 bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.5.5 bioMérieux Recent Development
13.6 Bio-Rad Laboratories
13.6.1 Bio-Rad Laboratories Company Details
13.6.2 Bio-Rad Laboratories Business Overview
13.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Introduction
13.6.4 Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.6.5 Bio-Rad Laboratories Recent Development
13.7 Meridian Bioscience
13.7.1 Meridian Bioscience Company Details
13.7.2 Meridian Bioscience Business Overview
13.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Introduction
13.7.4 Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.7.5 Meridian Bioscience Recent Development
13.8 Vista Diagnostics
13.8.1 Vista Diagnostics Company Details
13.8.2 Vista Diagnostics Business Overview
13.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction
13.8.4 Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.8.5 Vista Diagnostics Recent Development
13.9 Biogate Laboratories
13.9.1 Biogate Laboratories Company Details
13.9.2 Biogate Laboratories Business Overview
13.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Introduction
13.9.4 Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.9.5 Biogate Laboratories Recent Development
13.10 J.Mitra & Co. Ltd
13.10.1 J.Mitra & Co. Ltd Company Details
13.10.2 J.Mitra & Co. Ltd Business Overview
13.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Introduction
13.10.4 J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
13.10.5 J.Mitra & Co. Ltd Recent Development
13.11 Siemens Medical
10.11.1 Siemens Medical Company Details
10.11.2 Siemens Medical Business Overview
10.11.3 Siemens Medical Hepatitis C Virus (HCV) Antiviral Introduction
10.11.4 Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
10.11.5 Siemens Medical Recent Development
13.12 General Biologicals
10.12.1 General Biologicals Company Details
10.12.2 General Biologicals Business Overview
10.12.3 General Biologicals Hepatitis C Virus (HCV) Antiviral Introduction
10.12.4 General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020)
10.12.5 General Biologicals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hepatitis C Virus (HCV) Antiviral Key Market Segments
Table 2. Key Players Covered: Ranking by Hepatitis C Virus (HCV) Antiviral Revenue
Table 3. Ranking of Global Top Hepatitis C Virus (HCV) Antiviral Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HCV Antibody
Table 6. Key Players of HCV Viral Load
Table 7. Key Players of HCV Genotyping
Table 8. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Hepatitis C Virus (HCV) Antiviral Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Hepatitis C Virus (HCV) Antiviral Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Hepatitis C Virus (HCV) Antiviral Market Share by Regions (2015-2020)
Table 12. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Hepatitis C Virus (HCV) Antiviral Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Hepatitis C Virus (HCV) Antiviral Market Growth Strategy
Table 18. Main Points Interviewed from Key Hepatitis C Virus (HCV) Antiviral Players
Table 19. Global Hepatitis C Virus (HCV) Antiviral Revenue by Players (2015-2020) (Million US$)
Table 20. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players (2015-2020)
Table 21. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2019)
Table 22. Global Hepatitis C Virus (HCV) Antiviral by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hepatitis C Virus (HCV) Antiviral Product Solution and Service
Table 25. Date of Enter into Hepatitis C Virus (HCV) Antiviral Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020) (Million US$)
Table 28. Global Hepatitis C Virus (HCV) Antiviral Market Size Share by Type (2015-2020)
Table 29. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2021-2026)
Table 30. Global Hepatitis C Virus (HCV) Antiviral Market Size Share by Application (2015-2020)
Table 31. Global Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020) (Million US$)
Table 32. Global Hepatitis C Virus (HCV) Antiviral Market Size Share by Application (2021-2026)
Table 33. North America Key Players Hepatitis C Virus (HCV) Antiviral Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Hepatitis C Virus (HCV) Antiviral Market Share (2019-2020)
Table 35. North America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020) (Million US$)
Table 36. North America Hepatitis C Virus (HCV) Antiviral Market Share by Type (2015-2020)
Table 37. North America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020) (Million US$)
Table 38. North America Hepatitis C Virus (HCV) Antiviral Market Share by Application (2015-2020)
Table 39. Europe Key Players Hepatitis C Virus (HCV) Antiviral Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Hepatitis C Virus (HCV) Antiviral Market Share (2019-2020)
Table 41. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Hepatitis C Virus (HCV) Antiviral Market Share by Type (2015-2020)
Table 43. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Hepatitis C Virus (HCV) Antiviral Market Share by Application (2015-2020)
Table 45. China Key Players Hepatitis C Virus (HCV) Antiviral Revenue (2019-2020) (Million US$)
Table 46. China Key Players Hepatitis C Virus (HCV) Antiviral Market Share (2019-2020)
Table 47. China Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020) (Million US$)
Table 48. China Hepatitis C Virus (HCV) Antiviral Market Share by Type (2015-2020)
Table 49. China Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020) (Million US$)
Table 50. China Hepatitis C Virus (HCV) Antiviral Market Share by Application (2015-2020)
Table 51. Japan Key Players Hepatitis C Virus (HCV) Antiviral Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Hepatitis C Virus (HCV) Antiviral Market Share (2019-2020)
Table 53. Japan Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Hepatitis C Virus (HCV) Antiviral Market Share by Type (2015-2020)
Table 55. Japan Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Hepatitis C Virus (HCV) Antiviral Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Hepatitis C Virus (HCV) Antiviral Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Hepatitis C Virus (HCV) Antiviral Market Share (2019-2020)
Table 59. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Share by Type (2015-2020)
Table 61. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Share by Application (2015-2020)
Table 63. India Key Players Hepatitis C Virus (HCV) Antiviral Revenue (2019-2020) (Million US$)
Table 64. India Key Players Hepatitis C Virus (HCV) Antiviral Market Share (2019-2020)
Table 65. India Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020) (Million US$)
Table 66. India Hepatitis C Virus (HCV) Antiviral Market Share by Type (2015-2020)
Table 67. India Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020) (Million US$)
Table 68. India Hepatitis C Virus (HCV) Antiviral Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Hepatitis C Virus (HCV) Antiviral Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Hepatitis C Virus (HCV) Antiviral Market Share (2019-2020)
Table 71. Central & South America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Hepatitis C Virus (HCV) Antiviral Market Share by Type (2015-2020)
Table 73. Central & South America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Hepatitis C Virus (HCV) Antiviral Market Share by Application (2015-2020)
Table 75. Roche Diagnostics Company Details
Table 76. Roche Diagnostics Business Overview
Table 77. Roche Diagnostics Product
Table 78. Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 79. Roche Diagnostics Recent Development
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Siemens Company Details
Table 86. Siemens Business Overview
Table 87. Siemens Product
Table 88. Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 89. Siemens Recent Development
Table 90. Qiagen Company Details
Table 91. Qiagen Business Overview
Table 92. Qiagen Product
Table 93. Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 94. Qiagen Recent Development
Table 95. bioMérieux Company Details
Table 96. bioMérieux Business Overview
Table 97. bioMérieux Product
Table 98. bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 99. bioMérieux Recent Development
Table 100. Bio-Rad Laboratories Company Details
Table 101. Bio-Rad Laboratories Business Overview
Table 102. Bio-Rad Laboratories Product
Table 103. Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 104. Bio-Rad Laboratories Recent Development
Table 105. Meridian Bioscience Company Details
Table 106. Meridian Bioscience Business Overview
Table 107. Meridian Bioscience Product
Table 108. Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 109. Meridian Bioscience Recent Development
Table 110. Vista Diagnostics Business Overview
Table 111. Vista Diagnostics Product
Table 112. Vista Diagnostics Company Details
Table 113. Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 114. Vista Diagnostics Recent Development
Table 115. Biogate Laboratories Company Details
Table 116. Biogate Laboratories Business Overview
Table 117. Biogate Laboratories Product
Table 118. Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 119. Biogate Laboratories Recent Development
Table 120. J.Mitra & Co. Ltd Company Details
Table 121. J.Mitra & Co. Ltd Business Overview
Table 122. J.Mitra & Co. Ltd Product
Table 123. J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 124. J.Mitra & Co. Ltd Recent Development
Table 125. Siemens Medical Company Details
Table 126. Siemens Medical Business Overview
Table 127. Siemens Medical Product
Table 128. Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 129. Siemens Medical Recent Development
Table 130. General Biologicals Company Details
Table 131. General Biologicals Business Overview
Table 132. General Biologicals Product
Table 133. General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2015-2020) (Million US$)
Table 134. General Biologicals Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis C Virus (HCV) Antiviral Market Share by Type: 2020 VS 2026
Figure 2. HCV Antibody Features
Figure 3. HCV Viral Load Features
Figure 4. HCV Genotyping Features
Figure 5. Global Hepatitis C Virus (HCV) Antiviral Market Share by Application: 2020 VS 2026
Figure 6. Diagnostic Centers Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Home Use Case Studies
Figure 9. Hepatitis C Virus (HCV) Antiviral Report Years Considered
Figure 10. Global Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hepatitis C Virus (HCV) Antiviral Market Share by Regions: 2020 VS 2026
Figure 12. Global Hepatitis C Virus (HCV) Antiviral Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players in 2019
Figure 15. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue in 2019
Figure 17. North America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
C型肝炎ウイルス（HCV）の世界市場（～2026年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- C型肝炎ウイルスエンベロープタンパク質E2の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis C Virus Envelope Protein E2 Market The global Hepatitis C Virus Envelope Protein E2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis C Virus Envelope Protein E2 S…
- A型肝炎ウイルス細胞受容体2の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis A Virus Cellular Receptor 2 Market The global Hepatitis A Virus Cellular Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hepatitis A Virus Cellular Receptor 2 S…
- ウイルス性肝炎・レトロウイルス診断検査の世界市場（～2026年） Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patien…